Koers Lotus Pharmaceuticals, Inc. Other OTC
Aandelen
LTUS
US5457152032
Farmaceutische producten
Omzet 2009 | 57,82 mln. 54,08 mln. | Omzet 2010 | 72,7 mln. 67,99 mln. | Marktkapitalisatie | 69,15 mln. 64,68 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2009 | 16 mln. 14,96 mln. | Nettowinst (verlies) 2010 | 14 mln. 13,09 mln. | EV/omzet 2009 | 1,02 x |
Nettoschuld 2009 | 5,29 4,95 | Nettoschuld 2010 | 4,65 4,35 | EV/omzet 2010 | 0,95 x |
K/w-verhouding 2009 |
3,88
x | K/w-verhouding 2010 |
4,84
x | Werknemers | - |
Dividendrendement 2009 * |
-
| Dividendrendement 2010 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Georgene Rivers
CEO | Chief Executive Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Georgene Rivers
CEO | Chief Executive Officer | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+19,62% | 43,34 mld. | |
+20,44% | 21,96 mld. | |
+10,86% | 14,09 mld. | |
+13,07% | 13,64 mld. | |
+37,46% | 11,43 mld. | |
-8,59% | 6,86 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+8,46% | 5,22 mld. |